Gene therapy could ‘turn off’ severe allergies – Science Daily
Science Daily |
Gene therapy could ‘turn off’ severe allergies
Science Daily “We have now been able ‘wipe’ the memory of these T-cells in animals with gene therapy, de-sensitising the immune system so that it tolerates the protein. “Our work used an experimental asthma allergen, but this research could be applied to treat those … Gene therapy has been used to ‘switch off’ asthma symptomsScienceAlert Allergy treatment: Scientists claim breakthrough that could lead to …The Independent Gene therapy could offer life-long protection from severe allergies …First Newspaper 24 Newsmax all 6 news articles » |
|
Protein that stem cells require could be a target in killing breast cancer cells
Science Daily When a stem cell differentiates, it starts down a one-way path that will result in its specialization and eventually its death. For instance, a stem cell in the breast can become a luminal cell, one of the breast’s “milk factories.” Such cells have a … |
Fox News |
Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer
Newswise (press release) By combining chemotherapy with immunotherapy in this clinical trial, we are extending our options for treatment, and finding new hope,” said Dr. Pusztai. The phase I part of the trial sought to determine the safety and tolerability of durvalumab in … As scientists train the immune system to fight cancer, others look to combat costsMedical Xpress |
Fox News |
Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer
Newswise (press release) By combining chemotherapy with immunotherapy in this clinical trial, we are extending our options for treatment, and finding new hope,” said Dr. Pusztai. The phase I part of the trial sought to determine the safety and tolerability of durvalumab in … As scientists train the immune system to fight cancer, others look to combat costsMedical Xpress |
Futurism |
China Is About to Begin the World’s First Clinical Trial With Embryonic Stem Cells
Futurism Two clinical trials will begin using embryonic stem cells in China to treat Parkinson’s disease and blindness. These trials represent a new set of regulations on embryonic stem cells in China and possibly a new era of research around the world. |
|
Triple Immunotherapy Combo to Be Tested in Trial with Bladder Cancer Patients
Immuno-Oncology News Two immunotherapies, INO–5401 and INO–9012, will be combined with immune checkpoint inhibitor Tecentriq (atezolizumab) in a Phase 1/2 trial to test the combo’s safety and effectiveness in treating advanced bladder cancer. The trial, a result of … |